- Home
- NXPI vs GSK Comparison
NXPI vs GSK Comparison
Compare NXPI & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | GSK |
|---|---|---|
| Founded | 2006 | 1715 |
| Country | Netherlands | United Kingdom |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.2B | 95.3B |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | NXPI | GSK |
|---|---|---|
| Price | $228.96 | $48.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 1 |
| Target Price | ★ $245.17 | N/A |
| AVG Volume (30 Days) | 3.0M | ★ 4.2M |
| Earning Date | 10-27-2025 | 10-29-2025 |
| Dividend Yield | 1.78% | ★ 3.40% |
| EPS Growth | N/A | ★ 118.57 |
| EPS | ★ 8.08 | 1.79 |
| Revenue | $12,045,000,000.00 | ★ $43,237,357,842.00 |
| Revenue This Year | N/A | $6.56 |
| Revenue Next Year | $9.07 | $5.13 |
| P/E Ratio | $28.67 | ★ $27.33 |
| Revenue Growth | N/A | ★ 2.73 |
| 52 Week Low | $148.09 | $31.72 |
| 52 Week High | $255.45 | $49.31 |
Technical Indicators
Market Signals| Indicator | NXPI | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 64.61 | 60.04 |
| Support Level | $225.46 | $47.20 |
| Resistance Level | $232.66 | $49.31 |
| Average True Range (ATR) | 6.55 | 0.61 |
| MACD | 3.49 | -0.04 |
| Stochastic Oscillator | 84.44 | 81.02 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.